Can Alternative Hypotheses Survive In This Era Of Megaprojects?

Era Of Megaprojects? AUTHOR: Peter H. Duesberg, p.12 Scientific megaprojects costing taxpayers billions of dollars are, in some instances, the only means of reaching achievable goals. But if a megaproject becomes an undertaking that prejudicially focuses on a flawed theory promoted by a special-interest group, the project is counterproductive. The multibillion-dollar wars on AIDS and cancer are a case in point. AIDS research is now based on the hypothesis that the disease is caused by human

Written byPeter Duesberg
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Era Of Megaprojects?

AUTHOR: Peter H. Duesberg, p.12

Scientific megaprojects costing taxpayers billions of dollars are, in some instances, the only means of reaching achievable goals. But if a megaproject becomes an undertaking that prejudicially focuses on a flawed theory promoted by a special-interest group, the project is counterproductive.

The multibillion-dollar wars on AIDS and cancer are a case in point. AIDS research is now based on the hypothesis that the disease is caused by human immunodeficiency virus (HIV); the war on cancer is based largely on the theory that cancer is caused by either the activation of cellular oncogenes or the inactivation of antioncogenes. Both wars are waged by self-serving groups on behalf of hypotheses that neatly fit their limited expertise. Among the casualties are scientific minorities whose alternative hypotheses threaten the professional and commercial interests of these groups.

When a new theory deviates from that held by the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies